𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of drug efflux carriers in the healthy and diseased brain

✍ Scribed by Dirk M. Hermann; Ertugrul Kilic; Annett Spudich; Stefanie D. Krämer; Heidi Wunderli-Allenspach; Claudio L. Bassetti

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
851 KB
Volume
60
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of the anti-inflammator
Pharmacokinetics of the anti-inflammatory drug ximoprofen in healthy subjects and in disease states
✍ I. W. Taylor; T. Taylor; I. James; G. Doyle; G. Dorf; A. Darragh; L. F. Chasseau 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 606 KB

The pharmacokinetics of ximoprofen, a potent new non-steroidal anti-inflammatory agent, has been investigated in normal healthy subjects and in patients with hepatic or renal disease. After intravenous infusion of 22.8 mg to healthy subjects, plasma ximoprofen concentrations declined in a polyexpone

Potential role of size and hemodynamics
Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers
✍ Phapanin Charoenphol; Ryan B. Huang; Omolola Eniola-Adefeso 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 978 KB

Targeting of drug carriers to the vascular wall is of interest for localized delivery of therapeutics in many human diseases. Nanometer-sized spherical particles are widely proposed for use as carriers for vascular targeting, yet very little evidence has been presented as to their ability to interac

The role of auxin efflux carriers in the
The role of auxin efflux carriers in the reversible loss of polar auxin transport in the pea (Pisum sativumL.) stem
✍ David A. Morris; Claire F. Johnson 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 863 KB

Correlatively inhibited pea shoots (Pisum satirum L.) did not transport apically applied 14C-labelled indol-3yl-acetic acid ([14C]IAA), and polar IAA transport did not occur in internodal segments cut from these shoots. Polar transport in shoots and segments recovered within 24 h of removing the dom

Drug development in inflammatory bowel d
Drug development in inflammatory bowel disease: The role of the FDA
✍ Conor Lahiff; Sunanda Kane; Alan C. Moss 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 2 views

All medicinal compounds sold in the United States for inflammatory bowel disease (IBD) are regulated by the Food and Drug Administration (FDA) via a number of regulations dating back to 1906. The primary contemporary role of the FDA is in the assessment of safety and efficacy, and subsequent marketi